Cross-source identity
National Provider Identifier 1194725994 as it appears in every federal dataset Fonteum holds. Each row is a distinct public source; the chip carries the source and the snapshot date behind that field — the record-level form of the source-provenanced graph.
| Federal source | Key | What it provides | Provenance |
|---|---|---|---|
| CMS NPPES |
| NPI 1194725994 |
| Registry identity — psychiatrist, taxonomy 2084P0800X |
| Source:CMS NPPESSnapshot 2026-05-06 |
| CMS Medicare Part D | NPI 1194725994 | 22 drugs prescribed, 2024 | Source:CMS Part DSnapshot DY2024 |
Prescribing
Prescriptions written under Medicare Part D, aggregated by drug across the program. Totals reflect claims paid, not patients treated.
| Drug | Claims | Drug cost |
|---|---|---|
| Ingrezza(Valbenazine Tosylate) | 36 | $301,695 |
| Trintellix(Vortioxetine Hydrobromide) | 15 | $16,825 |
| Jornay Pm(Methylphenidate Hcl) | 13 | $6,506 |
| Lamotrigine Er(Lamotrigine) | 16 | $4,746 |
| Desvenlafaxine Succinate Er(Desvenlafaxine Succinate) | 41 | $4,670 |
Beneficiary counts below 11 are suppressed by CMS — the total shown is a lower bound.
Quality
CMS Quality Payment Program Merit-based Incentive Payment System (MIPS) final score, where this clinician participated. Absence of a score is not a quality signal — many clinicians report through a group or are exempt.
Enrollment & sanctions
Screening aid — re-confirm any match against the issuing list before acting. A clean result means no record was found in the federal OIG LEIE or the state Medicaid lists Fonteum currently holds (NY, OH, GA), not a guarantee that none exists elsewhere. Not a legal or credentialing certification.